Cai S, Wang X, Zhu S, Li J, Lou Z, Namba T, Komatsu K
School of Pharmaceutical Sciences, Beijing Medical University.
Zhongguo Zhong Yao Za Zhi. 1996 Dec;21(12):712-7, 760.
It has been found out that amony the 158 samples of commercial drug. Xixin (Herba Asari) collected from 28 provinces/cities of China, only three guarters are derived from the species specified in the Chinese Pharmacopoeia and the rest are not. One hundred and eleven samples are derived from Asarum heterotropoides var. mandshuricum and are presently used in 26 provinces/cities, 25 samples are derived from A. himalaicum and used in 10 provinces, the other 22 samples are derived from 9 species such as A. sieboldii, A. forbesii, etc.
据发现，在中国28个省/市采集的158份细辛（辽细辛）商业药材样本中，只有四分之三来自《中国药典》规定的物种，其余则不是。111份样本来自北细辛，目前在26个省/市使用，25份样本来自单叶细辛，在10个省使用，另外22份样本来自9个物种，如华细辛、短尾细辛等。
